Please use this identifier to cite or link to this item: https://doi.org/10.1002/bdrc.20208
Title: One step forward: The use of transgenic zebrafish tumor model in drug screens
Authors: Huang, X.
Nguyen, A.T.
Li, Z. 
Emelyanov, A.
Parinov, S.
Gong, Z. 
Keywords: Drug screening
Liver cancer
Transgenic fish
Zebrafish
Issue Date: Jun-2011
Citation: Huang, X., Nguyen, A.T., Li, Z., Emelyanov, A., Parinov, S., Gong, Z. (2011-06). One step forward: The use of transgenic zebrafish tumor model in drug screens. Birth Defects Research Part C - Embryo Today: Reviews 93 (2) : 173-181. ScholarBank@NUS Repository. https://doi.org/10.1002/bdrc.20208
Abstract: The zebrafish (Danio rerio) has been an experimental model in the developmental biology and toxicology since the 1950s. In recent years, with the aid of transgenic technology, it has also gained an increasing popularity to model human diseases, including various cancers. As a feasible vertebrate model for large-scale chemical screens, the zebrafish has also given us a new option for the search of potential anticancer drugs. It is hopeful that in the near future with automation and analytical tools, drug development processes will be significantly shortened for quick and effective identification of candidate drugs. © 2011 Wiley-Liss, Inc.
Source Title: Birth Defects Research Part C - Embryo Today: Reviews
URI: http://scholarbank.nus.edu.sg/handle/10635/102507
ISSN: 1542975X
DOI: 10.1002/bdrc.20208
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

12
checked on Sep 11, 2018

WEB OF SCIENCETM
Citations

10
checked on Sep 11, 2018

Page view(s)

51
checked on Aug 31, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.